Innate Pharma to Participate in Upcoming Investor Conference
MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that its investor relation team will participate in the following upcoming investor conference: Conference Portzamparc – Evenement Corporate Access, Paris (in-person event) Event Date: June 30, 2022 About Innate Pharma: Innate Pharma S.A. is a global, clinical-stage … [Read more…]
